Results 21 to 30 of about 568,663 (342)

Peripheral T-cell lymphoma [PDF]

open access: yesCancer, 1989
Peripheral T-cell lymphoma is the most common type of T-cell lymphoma seen in adults in the United States. Clinical data were reviewed from 134 cases of peripheral T-cell lymphoma diagnosed in three centers. The median age of the patients was 57 years (range, 4-97 years), 59% were male, and 36 patients (27%) had a history of a preceding disorder of the
James O. Armitage   +10 more
openaire   +2 more sources

Comparison of Diagnostic Cytomorphology of Natural Killer/T-Cell Lymphoma (Nasal Type) in Conventional Smears, Liquid-Based Preparations, and Histopathology

open access: yesCase Reports in Pathology, 2018
Natural killer (NK)/T-cell lymphoma is formally referred to as extranodal NK/T-cell lymphoma, nasal type (ENKTCL), in the 2008 and 2016 World Health Organization (WHO) classifications.
Chih-Yi Liu, Hui-Chih Tsai
doaj   +1 more source

Transcript-indexed ATAC-seq for precision immune profiling. [PDF]

open access: yes, 2018
T cells create vast amounts of diversity in the genes that encode their T cell receptors (TCRs), which enables individual clones to recognize specific peptide-major histocompatibility complex (MHC) ligands. Here we combined sequencing of the TCR-encoding
Buenrostro, Jason D   +21 more
core   +1 more source

Diagnosis of anaplastic large-cell lymphoma in a dog using CD30 immunohistochemistry [PDF]

open access: yes, 2018
Anaplastic large-cell lymphoma or null-cell lymphoma is a clinical entity reported in people, classified according to the unique appearance of large pleomorphic cells that express CD30.
Garden, O A   +7 more
core   +2 more sources

High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma

open access: yesActa Dermato-Venereologica, 2021
Cutaneous T cell lymphoma is a generally indolent disease derived from skin-homing mature T cells. However, in advanced stages, cutaneous T cell lymphoma may manifest aggressive clinical behaviour and lead to a poor prognosis.
Bufang Xu   +11 more
doaj   +1 more source

Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System. [PDF]

open access: yes, 2018
Chimeric antigen receptor (CAR) T cell therapy has proven clinically beneficial against B cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma. However, suboptimal clinical outcomes have been associated with decreased expansion and persistence of
Avanzi, Mauro P   +10 more
core   +1 more source

Anaplastic, T-cell, Non-Hodgkin's Lymphoma Presenting with Haematuria [PDF]

open access: yes, 2008
Non-Hodgkin's lymphoma (NHL) represents about 3% of new cancer cases[1]. Bladder involvement has been found in approximately 3-13% of NHL patients when studied at postmortem[2].
Abdelhadi, S   +3 more
core   +3 more sources

JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma

open access: yesHaematologica, 2019
T-cell/histiocyte-rich large B-cell lymphoma is a rare aggressive lymphoma showing histopathological overlap with nodular lymphocyte-predominant Hodgkin lymphoma.
Bianca Schuhmacher   +12 more
doaj   +1 more source

Cutaneous lymphoma in Japan: A nationwide study of 1733 patients [PDF]

open access: yes, 2014
Types of cutaneous lymphoma (CL) and their incidences may vary among geographic areas or ethnic groups. The present study aimed to investigate the incidences of various CL in Japan, using epidemiological data from a nationwide registration system for CL.
Agar   +48 more
core   +1 more source

Hepatosplenic T-Cell Lymphoma [PDF]

open access: yesIndian Journal of Hematology and Blood Transfusion, 2011
We report an uncommon case of 38-year-old male patient with Hepatosplenic T-Cell lymphoma (HSTCL) which is a rare aggressive form of Peripheral T-Cell lymphoma that is characterized by primary extranodal disease with malignant T-cell proliferation in the liver, spleen, and bone marrow.
Fahad I, Alsohaibani   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy